Bhamare
Deval A. Bhamare, Dhule IN
Patent application number | Description | Published |
---|---|---|
20130028141 | METHOD AND APPARATUS FOR ALLOCATING BACKBONE VLAN IDENTIFIERS - Methods and apparatuses for allocating backbone virtual local area network identifiers (BVIDs) to connection requests in a provider backbone bridging-traffic engineering (PBB-TE) network are described. During operation, a system (e.g., a network management system) can receive a set of connection requests for a set of connections that are desired to be set up in the PBB-TE network. Next, the system can allocate a BVID to each connection request in the set of connection requests so that, once the set of connection requests are set up in the PBB-TE network, conflicting connections in the PBB-TE network have different BVIDs. | 01-31-2013 |
Mayur Bhamare, Dhule IN
Patent application number | Description | Published |
---|---|---|
20150025103 | ORAL LIQUID CONCENTRATE COMPRISING BROMPHENIRAMINE, PSEUDOEPHEDRINE AND DEXTROMETHORPHAN - There is provided a liquid oral concentrate comprising combination of dextromethorphan, bromrpheniramine and pseudoephedrine or pharmaceutically acceptable salts thereof. The invention further provides process for preparation of such compositions. | 01-22-2015 |
Shailesh Suresh Bhamare, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20110206761 | STABLE DOSAGE FORMS OF ANTIHYPERTENSIVE AGENTS - The technical field of the present invention relates to stable solid dosage form comprising combination of antihypertensive agents. More particularly, the present invention relates to stable solid dosage form comprising combination of angiotensin converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) and calcium channel blocker (CCB). | 08-25-2011 |
20120178810 | Extended release formulation of an antiepileptic agent - The present invention relates to an extended release formulation of an antiepileptic agent. More particularly, the present invention relates to an extended release formulation of divalproex sodium. The present invention also relates to a process for the preparation of extended release formulation of divalproex sodium. | 07-12-2012 |